ISS A/S (LON:0QRS)
215.20
+0.52 (0.24%)
At close: Dec 23, 2025
ISS A/S Revenue
ISS A/S had revenue of 41.61B DKK in the half year ending June 30, 2025, with 8.55% growth. This brings the company's revenue in the last twelve months to 84.69B, up 4.53% year-over-year. In the year 2024, ISS A/S had annual revenue of 83.76B with 6.46% growth.
Revenue (ttm)
84.69B DKK
Revenue Growth
+4.53%
P/S Ratio
0.42
Revenue / Employee
259.41K DKK
Employees
326,483
Market Cap
4.06B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 83.76B | 5.08B | 6.46% |
| Dec 31, 2023 | 78.68B | 4.84B | 6.56% |
| Dec 31, 2022 | 73.84B | 2.48B | 3.47% |
| Dec 31, 2021 | 71.36B | 611.00M | 0.86% |
| Dec 31, 2020 | 70.75B | -6.95B | -8.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |